Package 65162-209-06

{"route": ["ORAL"], "spl_id": "fd384f73-fd86-4750-8d30-ecbb4289572a", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "upc": ["0365162209068"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["4f065674-4719-4c79-ba0d-549040d77f17"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (65162-209-06)", "package_ndc": "65162-209-06", "marketing_start_date": "20140430"}], "brand_name": "Nevirapine", "product_id": "65162-209_fd384f73-fd86-4750-8d30-ecbb4289572a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65162-209", "generic_name": "Nevirapine", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA078195", "marketing_category": "ANDA", "marketing_start_date": "20140430", "listing_expiration_date": "20261231"}